Literature DB >> 16716546

Nephrotoxicity study of total rhubarb anthraquinones on Sprague Dawley rats using DNA microarrays.

Ming Yan1, Lu-Yong Zhang, Li-Xin Sun, Zhen-Zhou Jiang, Xiao-He Xiao.   

Abstract

Total rhubarb anthraquinones (TRAs) are the active therapeutic components from the rhizomes of Rheum palmatum L. (Polygonaceae), which are widely used in traditional Chinese medicines (TCMs) and have been reported to have cell toxicity recently. This study focuses on the toxicity of TRAs on Sprague Dawley (S.D.) rats. TRAs administrated per os for 13 weeks induced nephrotoxicity on S.D. rats as renal tubule epithelial cells swelled and denatured in tissue slice examination. After high-density oligonucleotide microarrays scanning, we have identified mitogen-activated protein kinase (MAPK) kinase 6 to be the target gene which causes cell cycle arrest and proliferation inhibition and contributes to nephrotoxicity on S.D. rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716546     DOI: 10.1016/j.jep.2006.03.031

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  11 in total

1.  The UCP2-related mitochondrial pathway participates in rhein-induced apoptosis in HK-2 cells.

Authors:  Yong Mao; Mincheng Zhang; Jiapei Yang; Hao Sun; Dandan Wang; Xiaoxia Zhang; Feng Yu; Ji Li
Journal:  Toxicol Res (Camb)       Date:  2017-02-06       Impact factor: 3.524

Review 2.  Constipation-induced pressor effects as triggers for cardiovascular events.

Authors:  Yusuke Ishiyama; Satoshi Hoshide; Hiroyuki Mizuno; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-13       Impact factor: 3.738

3.  Shen-Kang protects 5/6 nephrectomized rats against renal injury by reducing oxidative stress through the MAPK signaling pathways.

Authors:  Meiyou Liu; Jisoo Park; Xiaoxiao Wu; Yuwen Li; Quangdon Tran; Kisun Mun; Yongjin Lee; Gang Min Hur; Aidong Wen; Jongsun Park
Journal:  Int J Mol Med       Date:  2015-08-26       Impact factor: 4.101

4.  Mitochondrial pathway and endoplasmic reticulum stress participate in the photosensitizing effectiveness of AE-PDT in MG63 cells.

Authors:  Kai-Ting Li; Qing Chen; Da-Wu Wang; Qin-Qin Duan; Si Tian; Juan-Wen He; Yun-Sheng Ou; Ding-Qun Bai
Journal:  Cancer Med       Date:  2016-10-03       Impact factor: 4.452

Review 5.  Advances in bio-active constituents, pharmacology and clinical applications of rhubarb.

Authors:  Yu-Jie Cao; Zong-Jin Pu; Yu-Ping Tang; Juan Shen; Yan-Yan Chen; An Kang; Gui-Sheng Zhou; Jin-Ao Duan
Journal:  Chin Med       Date:  2017-12-28       Impact factor: 5.455

6.  Oral colon-specific drug delivery system reduces the nephrotoxicity of rhubarb anthraquinones when they produce purgative efficacy.

Authors:  Pei Liu; Hongwei Wei; Jinhua Chang; Guangxin Miao; Xigang Liu; Zhongsi Li; Liyan Liu; Xiangrong Zhang; Cuizhe Liu
Journal:  Exp Ther Med       Date:  2017-08-17       Impact factor: 2.447

7.  Establishment and Validation of an In Vitro Screening Method for Traditional Chinese Medicine-Induced Nephrotoxicity.

Authors:  Zhe Ma; Xuexiao Cao; Xiao Guo; Meng Wang; Xiaoliang Ren; Ranran Dong; Rui Shao; Yan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-28       Impact factor: 2.629

8.  Toxic Effects of Rhamnus alaternus: A Rare Case Report.

Authors:  H Ben Ghezala; N Chaouali; I Gana; S Snouda; A Nouioui; I Belwaer; J Ouali; M Kaddour; W Masri; D Ben Salah; D Amira; H Ghorbal; A Hedhili
Journal:  Case Rep Emerg Med       Date:  2015-07-01

9.  An experimental study on providing a scientific evidence for seven-time alcohol-steaming of Rhei Rhizoma when clinically used.

Authors:  Yeomoon Sim; Hyein Oh; Dal-Seok Oh; Namkwon Kim; Pil Sung Gu; Jin Gyu Choi; Hyo Geun Kim; Tong Ho Kang; Myung Sook Oh
Journal:  BMC Complement Altern Med       Date:  2015-10-27       Impact factor: 3.659

10.  Alleviating the Intestinal Absorption of Rhein in Rhubarb through Herb Compatibility in Tiaowei Chengqi Tang in Caco-2 Cells.

Authors:  Ying Peng; Min Fan; Chongsheng Peng; Mengyue Wang; Xiaobo Li
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-30       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.